Delic Holdings Inc.

Delic Holdings Inc.

The World’s Premiere Psychedelic and Wellness Event

As a lifelong advocate of holistic health, Aubrey is most passionate about raising awareness for the benefits of psychedelic medicine. "Psychedelic medicines have been an inexorable part of my story for the last 22 years. I'm looking forward to sharing more of my story with everyone at the Meet Delic event," stated Marcus. The experient... Read More...

Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup

Leading Business and Entrepreneurial Voices Include Itefayo Harvey, Dina Burkitbayeva, Matt Zemon, Martin Tobias, George Goldsmith, Mark Goldfogel, Nanea Reeves, Katya Malievskaia, Dr. Jeff Chen, Ronan Levy, Jennifer Pereira, Barbara Branaman and Many Others to Take Part in First of its Kind Las Vegas Event November 6-7, 2021 Two-Day Exp... Read More...

Leading Psychedelic Wellness Company Delic Completes Acquisition of Ketamine Infusion Centers LLC, Adding Health Clinic Chain to Portfolio

Closing of Acquisition Expands Delic's Self-Sustaining Ecosystem with Existing Media/Education Platforms and Product Development Lab VANCOUVER, BC, July 6, 2021 - Delic Holdings, Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform has completed its acquisition (the "Acquisition") of Ketami... Read More...

Leading Psychedelic Wellness Company Delic Signs Definitive Agreement to Acquire Ketamine Infusion Centers Llc, Bringing Physical Retail Chain to Delic Portfolio

Acquisition to Expand Self-Sustaining Ecosystem with Existing Education Platform and Product Development Lab VANCOUVER, BC, June 8, 2021 - Delic Holdings Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform has signed a definitive agreement (the "Agreement") to acquire Ketamine Infusion C... Read More...

Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.

New Entity, Delic Labs, to Power Psilocybin and Cannabis R&D, IP and Innovative Product Lines for Mass Markets VANCOUVER, BC, May 27, 2021 - Delic Holdings Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness platform, is pleased to announce that it has acquired all of the issued and outstanding shares in... Read More...

Delic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Announces Closing of Non-Brokered Private Placement

VANCOUVER, BC, May 17, 2021 - Delic Holdings Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce that its acquisition target, Complex Biotech Discovery Ventures Ltd. ("CBDV"), has closed its previously-announced non-brokered private placement (the "Offering") of 11,441... Read More...